The Trump administration moved Friday to roll back Obama-era limits on emissions of ethylene oxide (EtO), a cancer-causing chemical widely used to sterilize medical equipment. The proposed rule, announced by the Environmental Protection Agency (EPA), aims to “safeguard the supply of essential medical equipment” and could save companies approximately $630 million over 20 years, according to the agency. This decision marks the latest in a series of deregulation efforts by the administration, raising concerns among environmental and public health advocates.
The move directly targets updated regulations for EtO emissions passed in 2024, stemming from pressure from environmental justice groups, particularly those in Louisiana’s “Cancer Alley.” These stricter rules sought a 90% reduction in EtO released from commercial sterilizers, aiming to lessen health hazards for nearby communities. The EPA now asserts that its own prior scientific findings – which determined EtO to be 60 times more carcinogenic than previously understood – should be reassessed. The debate centers on balancing public health with the availability of sterilized medical devices, a critical component of modern healthcare.
What is Ethylene Oxide and Why is it a Concern?
Approximately 50% of sterile medical devices in the United States rely on EtO for sterilization, particularly those that cannot withstand steam or radiation cleaning, Reuters reported. The colorless gas is similarly a key ingredient in the production of antifreeze, detergents, plastics, and adhesives. Exposure to EtO, even in the short term, can cause headaches, dizziness, nausea, and respiratory irritation, according to the federal Agency for Toxic Substances and Disease Registry. Longer-term exposure significantly increases the risk of cancers, including non-Hodgkin’s lymphoma and breast cancer. The EPA previously acknowledged EtO as a human carcinogen, stating on a now-deleted page of its website, “EtO is a human carcinogen. It causes cancer in humans.”
Industry Support and Environmental Opposition
The proposed rollback has drawn support from sterilization and chemical industry groups. The American Chemistry Council stated that the EPA’s previous rule “threatens to severely restrict access to vital medical products nationwide,” MSN reported. However, environmental and community organizations strongly oppose the move. Irena Como, senior attorney at the Southern Environmental Law Center, argued that the EPA’s 2024 rule was “an important and overdue step to reduce toxic ethylene oxide pollution and protect communities,” and that repealing it would “subject even more people…to harm that is entirely preventable.” A coalition of these groups has already challenged EtO emission exemptions in federal court, arguing that existing technology allows for compliance with stricter standards without raising costs.
The EPA’s proposal would offer facilities a choice: install continuous real-time monitoring systems for EtO emissions or comply with modified pollution control requirements for those emitting more than 10 tons annually. This action follows the administration’s broader pattern of rescinding regulations deemed burdensome to industries, including the recent repeal of the endangerment finding related to greenhouse gas emissions. Approximately 90 commercial sterilization facilities, operated by around 50 companies, would be affected by the proposed changes.
California Facilities and Ongoing Legal Challenges
California is home to roughly a dozen EtO sterilization facilities, including those operated by Sterigenics in Ontario and Vernon, which received presidential exemptions for their emissions in July. The Los Angeles Times detailed the concerns surrounding these facilities. The Southern Environmental Law Center and the Natural Resources Defense Council filed a lawsuit in January challenging these exemptions, asserting that viable technology exists for compliance with the stricter Biden-era standards.
.jpg)
The EPA will accept public comments on the proposal for 45 days after its publication in the Federal Register, with a final decision anticipated later this year. This latest action underscores the ongoing tension between regulatory oversight and industry concerns, particularly regarding essential medical supplies and economic impact. The outcome will likely have significant implications for communities near EtO sterilization facilities and the broader debate over environmental protection and public health.
Share your thoughts on this developing story in the comments below.
